941
Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Chronic Hepatitis C Who Have Not Achieved an Undetectable HCV RNA Level With Previous Interferon Based Therapy
Condition(s): Hepatitis C Last Updated: August 20, 2012Completed
1006 Clinical Trials for: Interferon-alpha, Page 48 of 51
Hide Studies Not Seeking New Volunteers
942
Safety and Efficacy Study of Peginterferon Lambda-1a vs. Peginterferon Alfa-2a, Plus Ribavirin in Subjects With Genotype 1 Hepatitis C
Condition(s): Hepatitis C Virus (HCV) Last Updated: April 10, 2013Not yet recruiting
943
A Study of Pegasys Monotherapy in Patients With Chronic Hepatitis B Who Have Participated in Previous Studies
Condition(s): Hepatitis B, Chronic Last Updated: May 7, 2013Active, not recruiting
944
A Study of the Pharmacokinetics And Pharmacodynamics of Intravenously Administered Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis C And Previous Non-Response to Pegylated Interferon And Ribavirin Combination Therapy
Condition(s): Hepatitis C, Chronic Last Updated: May 7, 2013Completed
945
A Study to Evaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C
Condition(s): Chronic Hepatitis C Last Updated: April 3, 2008Recruiting
946
ADVANCE Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) + Adefovir Dipivoxil in Patients With Hbe(-) Chronic Hepatitis B
Condition(s): Hepatitis B, Chronic Last Updated: October 14, 2011Completed
947
Add Vitamin D With Standard of Care for Chronic Hepatitis C Patients
Condition(s): Chronic Hepatitis C Last Updated: September 22, 2011Not yet recruiting
948
An Observational Study of Pegasys (Peginterferon Alfa-2a) Plus Ribavirin Based Regimens in Patients With Chronic Hepatitis C With Previous Treatment Failure
Condition(s): Hepatitis C, Chronic Last Updated: May 7, 2013Recruiting
949
A Study of Induction Dosing With PEGASYS (Peginterferon Alfa-2a [40KD]) Plus Copegus in Treatment-Naive Patients With Chronic Hepatitis C
Condition(s): Hepatitis C, Chronic Last Updated: July 30, 2010Completed
950
Oral Antivirals (GS-5885, Tegobuvir, and/or GS-9451) With Peginterferon Alfa 2a and Ribavirin in Treatment Experienced Subjects With Chronic Genotype 1 Hepatitis C Virus Infection
Condition(s): Hepatitis C, Chronic Last Updated: October 1, 2012Active, not recruiting
951
Long Term Effects of Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/B Co-Infection and Chronic Hepatitis C
Condition(s): Coinfection With Hepatitis B Virus and Hepatitis C Virus; Monoinfection With Hepatitis C Virus Last Updated: August 4, 2006Completed
952
Adherence in Patients Receiving PegIntron and Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04206)(TERMINATED)
Condition(s): Hepatitis C, Chronic; Hepacivirus Last Updated: July 25, 2008Terminated
953
A Study of Ribavirin in Combination With PEGASYS (Peginterferon Alfa-2a (40KD))in Patients With Chronic Hepatitis C
Condition(s): Hepatitis C, Chronic Last Updated: May 7, 2013Active, not recruiting
954
Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Positive Chronic Hepatitis B
Condition(s): Hepatitis B, Chronic Last Updated: December 19, 2012Recruiting
955
Three Regimens of PegIntron Plus Ribavirin in Previously Untreated Chronic Hepatitis C, Genotype 2 or 3 (Study P03548AM2)(COMPLETED)
Condition(s): Hepatitis C, Chronic Last Updated: April 8, 2010Completed
956
A Study of Switch From Nucleotide to Peginterferon Alfa-2a in CHB Patients Achieving HBeAg Loss and HBV DNA <200IU/ml
Condition(s): Chronic Hepatitis B Last Updated: November 1, 2011Active, not recruiting
957
A Follow-Up Study to WV19432, to Evaluate Long Term Post-Treatment Effects of PEGASYS (Peginterferon Alfa-2a(40KD))in Patients With HBeAg Positive Chronic Hepatitis B
Condition(s): Hepatitis B, Chronic Last Updated: May 7, 2013Active, not recruiting
958
TMC435-TiDP16-C208 - Phase III Trial of TMC435 in Treatment-naive, Genotype 1 Hepatitis C-infected Patients
Condition(s): Hepatitis C Last Updated: February 21, 2013Completed
959
Phase 2 Study of VX-950, Pegasys and Copegus in Hepatitis C
Condition(s): Hepatitis C Last Updated: December 17, 2007Completed
960
Viral Kinetic Study With Viramidine in Therapy-Naive Patients With Chronic Hepatitis C
Condition(s): Hepatitis C, Chronic Last Updated: June 21, 2012Terminated
